These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37297899)

  • 1. Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.
    Ayats-Vidal R; Bosque-García M; Cordobilla B; Asensio-De la Cruz O; García-González M; Castro-Marrero J; López-Rico I; Domingo JC
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 1-Year Supplementation with High-Rich Docosahexaenoic Acid (DHA) on Clinical Variables and Inflammatory Biomarkers in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial.
    Ayats-Vidal R; Bosque-García M; Cordobilla B; Asensio-De la Cruz O; García-González M; Loureda-Pérez S; Fernández-López E; Robert-Barriocanal E; Valiente-Planas A; Domingo JC
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy of MAG-DHA for Correcting AA/DHA Imbalance of Cystic Fibrosis Patients.
    Morin C; Cantin AM; Vézina FA; Fortin S
    Mar Drugs; 2018 May; 16(6):. PubMed ID: 29861448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
    O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
    Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in plasma and erythrocyte omega-6 and omega-3 fatty acids in response to intravenous supply of omega-3 fatty acids in patients with hepatic colorectal metastases.
    Al-Taan O; Stephenson JA; Spencer L; Pollard C; West AL; Calder PC; Metcalfe M; Dennison AR
    Lipids Health Dis; 2013 May; 12():64. PubMed ID: 23648075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docosahexaenoic and Eicosapentaenoic Intervention Modifies Plasma and Erythrocyte Omega-3 Fatty Acid Profiles But Not the Clinical Course of Children With Autism Spectrum Disorder: A Randomized Control Trial.
    de la Torre-Aguilar MJ; Gomez-Fernandez A; Flores-Rojas K; Martin-Borreguero P; Mesa MD; Perez-Navero JL; Olivares M; Gil A; Gil-Campos M
    Front Nutr; 2022; 9():790250. PubMed ID: 35425788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial.
    López-Neyra A; Suárez L; Muñoz M; de Blas A; Ruiz de Valbuena M; Garriga M; Calvo J; Ribes C; Girón Moreno R; Máiz L; González D; Bousoño C; Manzanares J; Pastor Ó; Martínez-Botas J; Del Campo R; Cantón R; Roy G; Menacho M; Arroyo D; Zamora J; Soriano JB; Lamas A
    Prostaglandins Leukot Essent Fatty Acids; 2020 Nov; 162():102186. PubMed ID: 33038833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
    Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
    Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis.
    Mehler SJ; May LR; King C; Harris WS; Shah Z
    Prostaglandins Leukot Essent Fatty Acids; 2016 Jun; 109():1-7. PubMed ID: 27269707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans.
    Ostermann AI; West AL; Schoenfeld K; Browning LM; Walker CG; Jebb SA; Calder PC; Schebb NH
    Am J Clin Nutr; 2019 May; 109(5):1251-1263. PubMed ID: 31006007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
    De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
    JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial.
    Hoogeveen EK; Geleijnse JM; Kromhout D; Giltay EJ
    Eur J Prev Cardiol; 2014 Nov; 21(11):1429-36. PubMed ID: 23774275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low unesterified:esterified eicosapentaenoic acid (EPA) plasma concentration ratio is associated with bipolar disorder episodes, and omega-3 plasma concentrations are altered by treatment.
    Saunders EF; Reider A; Singh G; Gelenberg AJ; Rapoport SI
    Bipolar Disord; 2015 Nov; 17(7):729-42. PubMed ID: 26424416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased tissue arachidonic acid and reduced linoleic acid in a mouse model of cystic fibrosis are reversed by supplemental glycerophospholipids enriched in docosahexaenoic acid.
    Mimoun M; Coste TC; Lebacq J; Lebecque P; Wallemacq P; Leal T; Armand M
    J Nutr; 2009 Dec; 139(12):2358-64. PubMed ID: 19828687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
    Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
    J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term.
    Castillo Salinas F; Montaner Ramón A; Castillo Ferrer FJ; Domingo-Carnice A; Cordobilla B; Domingo JC
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36500985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of n-3 fatty acids into plasma lipid fractions, and erythrocyte membranes and platelets during dietary supplementation with fish, fish oil, and docosahexaenoic acid-rich oil among healthy young men.
    Vidgren HM; Agren JJ; Schwab U; Rissanen T; Hänninen O; Uusitupa MI
    Lipids; 1997 Jul; 32(7):697-705. PubMed ID: 9252957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar eicosapentaenoic acid and docosahexaenoic acid plasma levels achieved with fish oil or krill oil in a randomized double-blind four-week bioavailability study.
    Yurko-Mauro K; Kralovec J; Bailey-Hall E; Smeberg V; Stark JG; Salem N
    Lipids Health Dis; 2015 Sep; 14():99. PubMed ID: 26328782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.